Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Reducing the cost of cancer care: how to bend the curve downward.

Smith TJ, Hillner BE, Kelly RJ.

Am Soc Clin Oncol Educ Book. 2012:e46-51. doi: 10.14694/EdBook_AM.2012.32.e46.

PMID:
24451830
[PubMed - in process]
Free Article
2.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.

PMID:
12065068
[PubMed - indexed for MEDLINE]
Free Article
3.

Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.

Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH.

Value Health. 2008 Mar-Apr;11(2):172-9. doi: 10.1111/j.1524-4733.2007.00242.x.

PMID:
18380630
[PubMed - indexed for MEDLINE]
4.

The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK.

Liu Z, Doan QV, Malin J, Leonard R.

Appl Health Econ Health Policy. 2009;7(3):193-205. doi: 10.2165/11314740-000000000-00000.

PMID:
19799473
[PubMed - indexed for MEDLINE]
5.

Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.

Perrier L, Lefranc A, Pérol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C.

Appl Health Econ Health Policy. 2013 Apr;11(2):129-38. doi: 10.1007/s40258-013-0011-7.

PMID:
23435861
[PubMed - indexed for MEDLINE]
6.
7.

[Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany].

Sehouli J, Goertz A, Steinle T, Dubois R, Plesnila-Frank C, Lalla A, von Minckwitz G.

Dtsch Med Wochenschr. 2010 Mar;135(9):385-9. doi: 10.1055/s-0030-1249174. Epub 2010 Feb 23. German.

PMID:
20180162
[PubMed - indexed for MEDLINE]
8.

American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.

Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, Von Roenn JH.

J Clin Oncol. 2012 Mar 10;30(8):880-7. doi: 10.1200/JCO.2011.38.5161. Epub 2012 Feb 6.

PMID:
22312101
[PubMed - indexed for MEDLINE]
9.

Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.

Berry SR, Bell CM, Ubel PA, Evans WK, Nadler E, Strevel EL, Neumann PJ.

J Clin Oncol. 2010 Sep 20;28(27):4149-53. doi: 10.1200/JCO.2010.29.1625. Epub 2010 Aug 9.

PMID:
20697077
[PubMed - indexed for MEDLINE]
10.

Implementation of cancer clinical care pathways: s successful model of collaboration between payers and providers.

Feinberg BA, Lang J, Grzegorczyk J, Stark D, Rybarczyk T, Leyden T, Cooper J, Ruane T, Milligan S, Stella P, Scott JA.

Am J Manag Care. 2012 May 1;18(5):e194-9.

PMID:
22694114
[PubMed - indexed for MEDLINE]
Free Article
11.

Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients.

Lathia N, Isogai PK, De Angelis C, Smith TJ, Cheung M, Mittmann N, Hoch JS, Walker S.

J Natl Cancer Inst. 2013 Aug 7;105(15):1078-85. doi: 10.1093/jnci/djt182. Epub 2013 Jul 19.

PMID:
23873405
[PubMed - indexed for MEDLINE]
12.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology.

J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.

PMID:
19581533
[PubMed - indexed for MEDLINE]
13.

Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

Feinberg BA, Lang J, Grzegorczyk J, Stark D, Rybarczyk T, Leyden T, Cooper J, Ruane T, Milligan S, Stella P, Scott JA.

J Oncol Pract. 2012 May;8(3 Suppl):e38s-43s. doi: 10.1200/JOP.2012.000564.

PMID:
22942833
[PubMed]
Free PMC Article
14.

Cost-effectiveness of pegfilgrastim versus six days of filgrastim for preventing febrile neutropenia in breast cancer patients.

Danova M, Chiroli S, Rosti G, Doan QV.

Tumori. 2009 Mar-Apr;95(2):219-26.

PMID:
19579869
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States.

Lyman G, Lalla A, Barron R, Dubois RW.

Curr Med Res Opin. 2009 Feb;25(2):401-11. doi: 10.1185/03007990802636817 .

PMID:
19192985
[PubMed - indexed for MEDLINE]
16.

Optimizing chronic disease management mega-analysis: economic evaluation.

Path-Theta Collaboration.

Ont Health Technol Assess Ser. 2013 Sep 1;13(13):1-148. eCollection 2013. Review.

PMID:
24228076
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
18.

Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.

Qaseem A, Alguire P, Dallas P, Feinberg LE, Fitzgerald FT, Horwitch C, Humphrey L, LeBlond R, Moyer D, Wiese JG, Weinberger S.

Ann Intern Med. 2012 Jan 17;156(2):147-9. doi: 10.7326/0003-4819-156-2-201201170-00011.

PMID:
22250146
[PubMed - indexed for MEDLINE]
19.

Behavioural interventions for type 2 diabetes: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(21):1-45. Epub 2009 Oct 1.

PMID:
23074526
[PubMed]
Free PMC Article
20.

Over-, under- and misuse of pain treatment in Germany.

Dietl M, Korczak D.

GMS Health Technol Assess. 2011 Apr 19;7:Doc03. doi: 10.3205/hta000094.

PMID:
21522485
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk